mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.25 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |